PearlPAK, developed by Dr. Rhonda Voskuhl at UCLA, is a prescription treatment designed to mitigate cognitive decline associated with menopause while alleviating common menopausal symptoms. This treatment leverages targeted neurological interventions to enhance cognitive function and improve quality of life for women experiencing menopause.
Funding
$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
During menopause, women often experience a sharp decline in estrogen and progesterone levels, leading to cognitive difficulties such as brain fog, memory loss, and reduced focus, as well as other symptoms like hot flashes and sleep disturbances. These hormonal changes can significantly impact a woman's quality of life and daily functioning.
Solution
PearlPAK is a prescription treatment designed to mitigate cognitive decline and alleviate common menopausal symptoms by leveraging a timed-release combination of estriol and progesterone. The treatment is designed to mirror a woman’s natural cycle, supporting the body with hormones to protect against difficulties with memory and concentration that can occur during menopause. Estriol, a type of estrogen, binds with beta receptors in the brain to support active memory and alleviate hot flashes and vaginal dryness. Progesterone, taken in the evening, may also help reduce sleep difficulties. PearlPAK is tailored to each woman’s specific needs, addressing the hormonal imbalances that contribute to cognitive decline and other menopausal symptoms.
Target Audience
PearlPAK is intended for women in perimenopause and early menopause experiencing cognitive difficulties and other common menopausal symptoms.
Features
- Prescription treatment delivered directly to the patient
- Timed-release dosage system designed to mirror a woman’s natural cycle
- Contains estriol to support active memory and alleviate hot flashes and vaginal dryness
- Contains progesterone to help reduce sleep difficulties
- Aims to slow cognitive decline and improve memory and focus
- Designed to reduce hot flashes and vaginal dryness
- Protected by U.S. Patent No. 10,369,158
- PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY
- Utilizes Estriol Therapy U.S. Patent No. 9,962,395
- COMPOSITIONS AND METHODS FOR MAINTAINING COGNITIVE FUNCTION